Please login to the form below

Not currently logged in
Email:
Password:

Jan Reiss moves from PAN Unlimited to IGNIFI

She joins as strategic business development director

IGNIFI Jan ReissUK-based IGNIFI has appointed Jan Reiss as its new strategic development director.

In this newly created role, Reiss will be responsible for driving new business and overseeing the strategic development of existing client partnerships.

Dave Watson, managing director of IGNIFI, said: “Jan's appointment is strategically significant, and will help us fuel growth and development in the pharmaceutical and healthcare sector – a key part of our health, active lifestyle and wellbeing focus.

“Jan's experience and insight enhances our existing skill set and will help bring our capabilities to a wider audience.”

Prior to joining the creative agency, Reiss served as an associate director in business development at PAN Unlimited, now PAN DJM Unlimited.

She also brings 11 years of client service experience in healthcare communications, having worked at CDM London, DDB Remedy, Langland and Medicus International.

Reiss said: “I am thrilled to have joined the team at IGNIFI. … there is an ethos at IGNIFI that we want our clients to truly enjoy working with us, which manifests itself in great client-agency relationship, and makes working here thoroughly enjoyable.”

10th February 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics